Видео с ютуба Medicines: Glofitamab

Глофитамаб для лечения рецидивирующих/рефрактерных крупноклеточных В-клеточных лимфом | Джошуа Бр...

Treatment Options of B-Cell Lymphoma: Glofitamab vs. Epcoritamab - Blood Cancer Video Library 2023

Glofitamab, a CD20/CD3 bispecific antibody, in the treatment of R/R DLBCL

Glofitamab as a SOC in third-line DLBCL and its potential in earlier lines of therapy

Phase II study of glofitamab in patients with R/R LBCL

Glofitamab induces durable complete remissions in patients with relapsed large B-cell lymphoma

Impact of TMTV on PFS following glofitamab treatment in R/R DLBCL

Glofitamab in R/R DLBCL: updated safety and efficacy data

The CRS-RS.5p predictive model of CRS after glofitamab treatment in patients with R/R DLBCL

What is the rationale behind step-up dosing of glofitamab in patients with MCL?

The STARGLO trial: glofitamab in combination with gemcitabine and oxaliplatin in R/R DLBCL

Bispecific Antibody Treatment in Non-Hodgkin Lymphoma: Glofitamab - Blood Cancers OncTalk 2023

Glofitamab-GemOx versus R-GemOx in transplant-ineligible R/R DLBCL: subgroup analysis of STARGLO

Michael Dickinson, MBBS, DMedSc, on Glofitamab Combination Trials Underway

Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cell Lymphoma

New Lymphoma treatment

Amisha Fnu, MD: Accelerated glofitamab dosing in high-risk R/R DLBCL real-world insights

Insights into Phase I/II study assessing fixed-duration glofitamab treatment for R/R LBCL

A Phase II study of glofitamab plus Pola-R-CHP for patients with high-risk DLBCL

Glofitamab & Pirtobrutinib for Relapsed/Refractory Mantle Cell Lymphoma -Blood Cancers Video Library